TB diagnosis in India Challenges and opportunities
Dr Sanjay Sarin, Regional Director, Global Health (Central & South Asia Pacific), BD elaborates on the challenges and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Epidemiology of TB in India
Dr Giridhar R Babu, Associate Professor, Public Health Foundation of India discusses the imminent need for improved diagnostics…
Glass Ceiling for Women: Myth Or Reality?
Is there a glass ceiling that prevents the growth of women in the Indian life science industry? Usha Sharma seeks answers to this…
Decoding the better half of India
Sreedevi Yallamrazu, Sr Strategic Analyst, CubeX - A Division of Sorento Healthcare Communications, highlights the focus areas in…
Compulsory Licensing: The Wild Card
If the recent recommendations of the Health Ministry are anything to go by, Compulsory Licensing (CL) might soon be a reality for…
Great Expectations from Budget 2013-14
This year's budget could very well prove to be a crucial and determining factor in the elections next year. The expectations are…
To poll or not to poll
Milind Sathe, Deputy General Manager-Projects, Unichem Laboratories, submits a qualitative analysis of responses to a recently…
Caring Cadila
With founder Indravadan A Modi at the helm, Cadila Pharmaceuticals played a pivotal role in Gujarat's vibrant growth trajectory.…
Fulfilling the promise of biotechnology for India
Despite the immense potential, a lot still needs to be put in place to turn India into a biotechnology hub says James C Greenwood,…
Compulsory licensing for anti-cancer drugs: concerns and future ahead
Rai S Mittal, Partner, Titus & Co, Advocates, opines that the recent recommendation for compulsory licensing by the Government…
More Regulatory Rigour on the cards
Over the past few months, the CDSCO's directives have hinted at a new resolve to tighten regulation of clinical trials. Industry…
Fellowship of the chain: Dietary supplements & nutraceuticals
Dietary supplements and nutraceuticals were brought under the purview of the Food Safety and Standards Act 2006 (FSSA 2006),…
No Cure for Pharma Frauds?
Frauds in the pharma industry is not a new thing today. Sachin Jagdale reports on some common unethical practices leading to life…
India-China Bilateral Trade: Adjusting the balance
Over the years India-China bilateral trade has largely remained in favour of China. Recently the Indian Prime Minister Dr Manmohan…
Patent backlog A qualitative analysis
The patent backlog has assumed worrying proportions in both developed and developing nations. This legal uncertainty adds to the…
Bribery, corruption key compliance risks to pharma cos: KPMG India Fraud Survey 2012
Procurement, sales and distribution and inventory amongst top three most vulnerable processes to fraud risks in the sector
Omkar Speciality Chemicals: Thinking big
Omkar Speciality Chemicals is one of the fastest growing chemical companies in India. Sachin Jagdale reports about company's…
Violators of law… Drug Regulatory Authorities (DRAs)
As pharmaceutical majors from developed markets are expected to outsource huge amount of manufacturing to low cost destinations in…
Industry awaits final word on ‘brand ban’
After the hue and cry over the Ministry of Health and Family Welfare's directive to stop granting or renewing manufacturing…
Singapore A global-Asia pharmaceutical hub
Lee Eng Keat, International Director (Asia Pacific) of the Singapore Economic Development Board (EDB), speaks about the synergy…